Memokath™

Memokath™ is a unique range of biocompatible nickel-titanium stents used to safely counteract urinary tract obstructions. Learn more about Memokath™ and each product group below.

What is Memokath™?

Memokath™ is a urological stent produced in advanced nickel-titanium alloy with memory-shape effect, developed with the aim of providing free flow of urine through obstructions in the urinary system. Memokath™ stents have a tight spiral structure which allow it to conform and adapt to the natural curves of the urinary tract, while making tissue in-growth between the coils difficult. The Memokath™ range consists of five different product groups each customized to treat obstructions in their respective areas of the urinary system.

How does Memokath™ work?

Memokath™ is inserted unexpanded into the desired location in the urinary system. Once positioned correctly across the stricture, sterile water above 55°C is flushed through the system, allowing the advanced nickel-titanium formula to expand either one, or both ends of the coil. The expansions act as anchors keeping Memokath™ safely in place, allowing urine to flow freely. When exchange of Memokath™ is desired, sterile water below 7°C is flushed through the system softening the coils whereby Memokath™ can be removed as easily as it was inserted.

Memokath™ – a new generation of easily removable stents

Unlike early examples of urological metallic stents, Memokath™ is easily removable due to its advanced NiTinol-formula, and can safely be exchanged, or removed altogether even after years insitu.

Products 028 Prostate 044 Urethra 045 Urethra 045 Bladderneck 051 Ureter
Illustrations
Indications
  • Prostatic obstructions
  • Bulbar urethral strictures
  • Penile urethral strictures
  • Bladder neck strictures
  • Ureteric strictures
Etiologies
  • Benign prostatic enlargement
  • Malignant prostatic enlargement
  • Trauma
  • Instrumentations
  • Sexually transmitted deceases
  • Trauma
  • Instrumentations
  • Sexually transmitted deceases
  • Trauma
  • Instrumentations
  • Sexually transmitted deceases
  • Post-TURP or -radical prostatectomy
  • Cancer
  • Trauma
  • Instrumentations
  • Kidney transplant
  • Post surgery scarring
  • Retroperitoneal Fibrosis
Patient Examples
  • Unfit for, or unwilling to undergo surgery
  • Catheter patients
  • Dementia patients
  • Anticoagulant patients
  • Waiting list patients
  • Repeat dilatation or incision patients
  • Catheter patients
  • Unfit for, or unwilling to undergo surgery
  • Failed surgery patients
  • Repeat dilatation or incision patients
  • Catheter patients
  • Unfit for, or unwilling to undergo surgery
  • Failed surgery patients
  • Repeat dilatation or incision patients
  • Catheter patients
  • Failed surgery patients
  • Repeat JJ-catheter exchange patients
  • Repeat dilatation or incision patients
  • Unfit for, or unwilling to undergo surgery
Replaces
  • Foley catheters
  • TURP
  • Laser
  • TUMT
  • Aquablation
  • CISC
  • Foley catheters
  • Repeated incisions
  • Repeated dilations
  • Urethroplasty
  • CISC
  • Foley catheters
  • Repeated incisions
  • Repeated dilations
  • Urethroplasty
  • CISC
  • Foley catheters
  • Repeated incisions
  • Repeated dilations
  • CISC
  • Repeated JJ-catheter exchanges
  • Repeated incisions
  • Repeated dilatations
  • Nephrostomies
  • Pyeloplasty
Advantages
  • 100% reversible
  • No tissue ingrowth
  • Minimal risk of infection
  • No impotence
  • No incontinence
  • Normal voluntary urination control
  • Safe & efficient for high risk patients
  • Short procedure time
  • Minimally invasive treatment
  • Cost effective
  • 100% reversible
  • Minimal tissue ingrowth
  • Minimal risk of infection
  • High rate of stricture resolution
  • Minimally invasive treatment
  • Cost effective
  • Much higher QoL compared to competing treatments
  • 100% reversible
  • No tissue ingrowth
  • Minimal risk of infection
  • High rate of stricture resolution
  • Minimally invasive treatment
  • Cost effective
  • Much higher QoL compared to competing treatments
  • 100% reversible
  • No tissue ingrowth
  • Minimal risk of infection
  • High rate of stricture resolution
  • Minimally invasive treatment
  • Cost effective
  • Much higher QoL compared to competing treatments
  • 100% reversible
  • No tissue ingrowth
  • Minimal risk of infection
  • Less need for repeated stent exchanges, GA, and hospital admission
  • Less reflux, bladder irritation and flank pain than JJ stents
  • Minimally invasive treatment
  • Much higher QoL compared to similar procedures
Procedure Time
  • 10-15 minutes
  • 20-30 minutes
20-30 minutes
  • 20-30 minutes
  • 20-30 minutes
Anaesthesia
  • Local
  • Local
  • General or spinal if VIU is needed before insertion
  • Local
  • General or spinal if VIU is needed before insertion
  • Local
  • General or spinal if VIU is needed before insertion
  • General or spinal
Available Sizes
  • 30, 35, 40, 45, 50, 60 and 70 mm.
  • Special sizes available on request
  • 20, 30, 40, 50, 60, 70 and 80 mm.
  • 90 mm. available on request
  • 10, 20, 30, 40, 50, 60 and 70 mm.
  • 5, 10, 20, 30, 40, 50, 60 and 70 mm.
  • Single cone: 30, 60, 100, 150, 200 mm.
  • Double cone: 60, 80, 100 and 120 mm.
  • Special sizes available on request
Learn more
Learn more
Learn more
Learn more
Learn more

Solutions for all areas of the urinary tract

The Memokath™ Stent Program has been developed and improved over time through dedicated R&D efforts and aspirations of providing the highest quality of life for patients suffering from urinary tract obstructions. The Memokath™ Stent Program offers solutions to all common strictures and obstructions in the urinary system and continues to hold relevance among an ever growing selection of competing treatment regimens.

Please visit Clinical Evidence to learn about the body of clinical and health-economic evidence for the Memokath™ range.

Memokath™we treat urinary tract obstructions